BHVN – biohaven ltd. common shares (US:NASDAQ)
Stock Stats
News
4/26
07:20 am
bhvn
Low
Independent Director of Biohaven John Childs Buys 3.2% More Shares [Yahoo! Finance]
4/23
11:52 am
bhvn
Low
Biohaven Ltd. (NYSE: BHVN) had its price target raised by analysts at UBS Group AG from $59.00 to $60.00. They now have a "buy" rating on the stock.
4/22
04:13 pm
bhvn
Medium
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares [Yahoo! Finance]
4/22
04:05 pm
bhvn
Medium
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
4/18
10:22 am
bhvn
Low
Biohaven Ltd. (NYSE: BHVN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
11/14/2023
04:05 pm
BHVN
-2.5%
MISS
7/31/2023
06:59 am
BHVN
10.4%
MISS
5/12/2023
04:30 pm
BHVN
6.9%
BEAT
5/12/2023
04:30 pm
BHVN
6.9%
BEAT
4/23
11:39 am
Maintains
Buy
Buy
UBS
Low
-2.1%
4/18
10:22 am
Reiterates
Overweight
Cantor Fitzgerald
Low
2.7%
4/18
09:48 am
Reiterates
Overweight
Cantor Fitzgerald
Low
-0.4%
4/10
02:14 pm
Reiterates
Overweight
Cantor Fitzgerald
Low
0.6%
4/10
01:26 pm
Reiterates
Overweight
Cantor Fitzgerald
Low
0.1%
5/1
05:23 pm
bhvn
Low
Form 8-K Biohaven Ltd. For: Apr 30
4/25
07:34 am
bhvn
Low
Form 4 Biohaven Ltd. For: Apr 24 Filed by: Bailey Gregory
4/23
07:55 am
bhvn
Low
Form 4 Biohaven Ltd. For: Apr 22 Filed by: Bailey Gregory
4/23
07:54 am
bhvn
Low
Form 4 Biohaven Ltd. For: Apr 22 Filed by: Coric Vlad
4/23
07:54 am
bhvn
Low
Form 4 Biohaven Ltd. For: Apr 22 Filed by: CHILDS JOHN W
Show more
Top News Gainers
4/16 Form DEFA14A Biohaven Pharmaceutical 14.2%
2/10 Biohaven's Rimegepant Named To Cortellis 2020 Potential Blockbuster "Drugs to Watch" List 12.9%
7/22 Biohaven Provides Update On Phase 2/3 Alzheimer's Disease Clinical Trial: Over 400 Patients Enrolled 10.4%
9/4 Form 8-K Biohaven Pharmaceutical For: Sep 04 9.3%
2/27 Biohaven's NURTEC™ ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults 8.1%
7/15 Biohaven's Positive Phase 3 Trial of Rimegepant Zydis® Orally Dissolving Tablet for Acute Treatment of Migraine Published in The Lancet 7.6%
3/12 Form 5 Biohaven Pharmaceutical For: Dec 31 Filed by: Coric Vlad 7.2%
5/7 Form 8-K Biohaven Pharmaceutical For: May 07 6.5%
4/27 Biohaven Enters Into Agreement With Genpharm for Distribution of NURTEC™ ODT in the Middle East 5.9%
1/27 Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.7%
Top News Decliners
3/31 Form 8-K Biohaven Pharmaceutical For: Mar 30 -13.6%
6/17 Biohaven Announces Proposed Public Offering Of Common Shares -12.4%
1/10 Form 4 Biohaven Pharmaceutical For: Jan 08 Filed by: Stock Elyse -11.2%
12/17 Biohaven Pharma says acute migraine treatment succeeds in study [Reuters] -10.7%
1/28 Biohaven Announces Proposed Public Offering Of Common Shares -8.8%
6/18 Biohaven Announces Pricing Of $300 Million Public Offering Of Common Shares -7.2%
12/6 Biohaven Pharma to continue late-stage study of Alzheimer's treatment [Reuters] -7.0%
4/7 Biohaven Enters Into Collaboration With Cove, Leading Migraine Telemedicine Platform, To Enhance Accessibility Of NURTEC™ ODT -5.9%
2/10 Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint -5.9%
3/30 Biohaven Achieves Positive Results in Pivotal Trial of Oral NURTEC™, Dosed Every Other Day, for the Preventive Treatment of Migraine -5.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3